New Research Division at the Leibniz Institute for Immunotherapy (LIT): “Tailored T-Cell Diversity”, headed by Prof. Carmen Gerlach
We’re thrilled to have Prof. Carmen Gerlach join our team. She has been dedicated to understanding diversification within CD8+ T cell responses for 20 years. Her new Research Division “Tailored T-Cell Diversity” works on T cell immunotherapy of cancer and inflammatory diseases.
Article Details
-
Date Published
May 22, 2025
About Prof. Carmen Gerlach
Carmen Gerlach holds a Bachelor and Master of Science in Biomedical Sciences from Leiden University in Leiden, the Netherlands. She performed her doctoral training under supervision of Ton Schumacher at the Netherlands Cancer Institute in Amsterdam, graduating with a PhD in 2012.
Prof. Gerlach performed her postdoctoral research (2011-2017) under supervision of Ulrich von Andrian at Harvard Medical School in Boston, USA, and spent 8 months as Visiting Scholar in Nir Yosef’s lab at the University of California Berkeley, USA, to gain insights into computational immunology.
She started her independent lab at the end of 2017 as Assistant Professor at Karolinska Institutet in Stockholm, Sweden, where she became Principal Researcher in 2022.
Prof. Gerlach was recruited as W3 Professor to the University of Regensburg and now starts the research division “Tailored T-cell diversity” at the LIT.
Prof. Carmen Gerlach, Head of Research Division "Tailored T-Cell Diversity"
Explore our Research Division in greater depth!
Get to know our team and find out more about our pioneering research.